This article appears in the following Europace issue: Spotlight Issue: Cardiac Imaging in EP and CRT [View the issue table of contents]
IMAGING IN CRT
The role of tissue Doppler and strain imaging in predicting response to CRT
The Cardiovascular Institute, University of Pittsburgh, Scaife Hall 564, 200 Lothrop Street, Pittsburgh, PA 15213-2582, USA
* Corresponding author. Tel: +1 412 647 6570; fax: +1 412 647 0568. E-mail address: gorcsanj{at}upmc.edu
| Abstract |
|---|
|
|
|---|
Aims: Several echocardiographic methods have been proposed to assist in patient selection for cardiac resynchronization therapy (CRT). The prevailing hypothesis is that echocardiography may be superior to the electrocardiogram to qualify abnormalities in regional mechanical activation, because QRS widening is only a surrogate for ventricular dyssynchrony.
Methods and results: This review will focus on tissue Doppler (TD) and strain imaging, including their advantages and disadvantages for patient selection for CRT. Colour-coded TD remains to be one of the most promising means to quantify dyssynchrony. Tissue Doppler velocity data have a more favourable signal-to-noise ratio compared with TD strain or strain rate imaging. However, velocity data are affected by Doppler angle of incidence and passive or tethering motion. A newer promising method is speckle-tracking echocardiography to calculate strain. An opposing wall delay in peak TD velocity
65 ms has been associated with clinical and ventricular response to CRT. The initial experience with speckle tracking used the short-axis view to calculate radial strain. An anterior-septal to posterior wall peak strain delay
130 ms has been associated with an ejection fraction response to CRT.
Conclusion: Although no ideal echo-Doppler method has yet been discovered to select patients for CRT, technical refinements and advances in understanding of pathophysiology continue to favourably impact on potential clinical applications.
Key Words: Echocardiography, Pacing therapy, Doppler ultrasound, Congestive heart failure
| Introduction |
|---|
|
|
|---|
Cardiac resynchronization therapy (CRT) is an important advance for heart failure patients with depressed left ventricular (LV) ejection fraction and prolonged electrical activation. Patients have benefited from CRT by experiencing improvements in exercise capacity, quality of life, ventricular function, and survival.1
| Tissue Doppler imaging |
|---|
|
|
|---|
The largest body of published data for imaging to assess LV dyssynchrony and predict response to CRT exists for TD.8
|
Several post-processing TD methods exist, including displacement imaging, strain rate, and TD strain imaging. Several authors have had differences of opinion on the preferred approach.
Tissue Doppler data are intimately affected by ultrasound beam angle of incidence, and velocity cannot differentiate active from passive motion. However, because the fundamental determination of the Doppler equation is velocity, it appears that TD velocity data have the best balance of a robust signal-to-noise ratio and relatively more simple analysis that can be applied to most patients.19
,27
,28
A key technical element appears to be the need for an ultrasound system with colour-TD capabilities at high frame rates >100 Hz. This is because the wide-sector scanning of colour-TD systems may result in lower frame rate image acquisition which can impact the temporal resolution to accurately characterize LV mechanical dyssynchrony. A second key element is a careful and systematic approach to the user interface for off-line analysis. Since the goal is to determine the timing of a particular LV segment, the user must employ a manual spatial averaging approach to derive the most reproducible TD velocity signal. This is accomplished by defining the myocardial area of interest for tissue velocity sampling, then using visual feedback from the TD velocity curves in order to manually fine-tune the sampling area to produce the strongest signal-to-noise ratio.7
This process requires a relatively large region of interest (ROI) for TD signal averaging over an area of the myocardium (7 x 15 mm, for example) with the operator then moving the ROI within the LV segment, searching for the most reproducible signal without high-frequency noise. This step appears to be one of the most important steps to determine a reproducible time–velocity curve.
Among the TD velocity approaches that have been advocated, the vast majority support limiting the analysis of peak velocity to the ejection period. This is to exclude the isovolumic contraction spike before ejection, and in particular, exclude the post-systolic high-velocity spikes occurring after aortic valve closure, which are non-specific. The post-systolic velocity data may be particularly misleading in patients with ischaemic heart disease and scar that has a large amount of post-systolic recoil that is a confounding variable to dyssynchrony analysis.19
,29
The simplest approach is to determine aortic valve opening and aortic valve closure from the routine blood flow Doppler signal sampled from the LV outflow tract, with this timing transferred to the TD time–velocity analysis of the LV walls. The most straightforward method is to determine the opposing wall delay by measuring the difference in time to peak ejection velocities between septal and lateral wall segments in the apical four-chamber (Figures 1
–3) or long-axis view. The most widely used cut-off value for significant dyssynchrony is an opposing wall delay of
65 ms. The apical two-chamber view may be an alternative, but the four-chamber and apical long-axis views that contain septal and free-wall segments within the same plane have the highest yield for detecting dyssynchrony. An alternate method is the 12-site standard deviation method, also known as the Yu index. The most reproducible segmental peak velocities are sought from basal and mid-ventricular levels of the LV walls in the apical four-chamber, two-chamber, and long-axis view to yield 12 segments. An identical method of manual signal averaging is followed, moving the ROI within the segment inferiorly–superiorly, and side-to-side within the wall to determine the optimal peak velocity during ejection that is most reproducible without signal noise. One then needs to measure the time from the onset of the QRS complex to 12 corresponding peak velocities, followed by calculating the standard deviation (SD) of those values. A cut-off value often used as significant dyssychrony for the Yu index is an SD of
33 ms.18
,30
The Yu index appears to be an accurate means to qualify LV dyssynchrony, but is more complex than the opposing wall delay method described above, and may be too difficult to apply in some clinical laboratories for routine clinical use.
|
|
|
Tissue Doppler strain imaging has, most frequently, been applied to the apical views to assess LV longitudinal shortening. For TD strain imaging to perform successfully, it requires LV wall deformation to be in the same direction as the Doppler angle of incidence.20
| Speckle-tracking strain imaging |
|---|
|
|
|---|
Speckle tracking is a relatively new advance that may be applied to routine grey-scale echocardiographic images. The speckle-tracking software tracks patterns of speckle within the myocardial wall to determine relative thickening and thinning, or shortening and lengthening. The initial experience for CRT was using the short-axis images to calculate radial strain, or % wall thickening.33
130 ms (Figures 4
|
|
|
| Alternate echo-Doppler means to assess dyssynchrony |
|---|
|
|
|---|
Another important lesson learned form the PROSPECT study is that the routine pulsed-Doppler measures of interventricular mechanical delay (IVMD) have a high yield and are very reproducible.26
40 ms has been shown to indicate significant interventricular dyssynchrony that is responsive to CRT. An even longer IVMD of
49 ms was shown to be associated with patient outcome in the CARE-HF study.37| Current and future applications |
|---|
|
|
|---|
Current applications of all echo-Doppler methods to assess LV dyssynchrony in patients evaluated for CRT are controversial. In the wide QRS complex patients, currently defined as >120 ms, routine implantation criteria are advocated including heart failure functional class III or IV (on optimal medical therapy) and depressed ejection fraction
35%. The consensus is that patients who meet these criteria should have CRT, and that an imaging dyssynchrony study should not be part of their selection. The next frontier is to use these echo-Doppler methods to identify patients with narrow QRS complexes and mechanical dyssynchrony who may potentially benefit from CRT.14
65 ms. It was a relatively small study with mixed results that may have been underpowered to be conclusive. CRT had no effect on the primary endpoint of peak oxygen consumption, but had a significant favourable effect on New York Heart Association Functional Class, which was a secondary endpoint. The RethinQ results were not entirely discouraging because perhaps better patient selection or better dyssynchrony criteria may result in a convincing therapeutic benefit of CRT in these patients. Interestingly, patients with QRS duration in the range of 120–130 ms with echo-Doppler evidence of dyssynchrony showed significant benefit when randomized to CRT.42
120 ms, currently. Evaluation of the patient for dyssynchrony with a borderline QRS duration, or perhaps the borderline ejection fraction or borderline heart failure functional class, is reasonable in selected clinical scenarios. Of the many techniques proposed, TD longitudinal velocities, speckle-tracking radial strain, and IVMD currently appear to be among the most promising. Undoubtedly, refinements in the technology of the ultrasound equipment and our understanding of the role that dyssynchrony along with other confounding variables play in the CRT patient will result in an evolution of the approach. This remains a fascinating field with great promise to improve the therapeutic applications of CRT to benefit our patients with heart failure. Conflict of interest: J.G. III receives modest research grants from GE, Toshiba, Medtronic, St Jude and Biotronik.
| References |
|---|
|
|
|---|
[1] Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med (2002) 346:1845–53.
[2] Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med (2004) 350:2140–50.
[3] Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 352:1539–49.
[4] Kass DA. Ventricular resynchronization: pathophysiology and identification of responders. Rev Cardiovasc Med (2003) 4:S3–13.
[5] Kass DA. Predicting cardiac resynchronization response by QRS duration: the long and short of it. J Am Coll Cardiol (2003) 42:2125–7.
[6] Kass DA. Cardiac resynchronization therapy and cardiac reserve: how you climb a staircase may alter its steepness. Circulation (2006) 113:923–5.
[7] Gorcsan J 3rd, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, et al. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting—a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr (2008) 21:191–213.[CrossRef][Web of Science][Medline]
[8] Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq C, Schalij MJ, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol (2004) 44:1–9.
[9] Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol (2004) 44:1834–40.
[10] Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, van der Wall EE, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation (2005) 112:1580–6.
[11] Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JW, Garrigue S, et al. Cardiac resynchronization therapy: Part 1—issues before device implantation. J Am Coll Cardiol (2005) 46:2153–67.
[12] Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JW, Garrigue S, et al. Cardiac resynchronization therapy: Part 2—issues during and after device implantation and unresolved questions. J Am Coll Cardiol (2005) 46:2168–82.
[13] Bleeker GB, Bax JJ, Schalij MJ, van der Wall EE. Tissue Doppler imaging to assess left ventricular dyssynchrony and resynchronization therapy. Eur J Echocardiogr (2005) 6:382–4.
[14] Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol (2006) 48:2243–50.
[15] Gorcsan J 3rd, Kanzaki H, Bazaz R, Dohi K, Schwartzman D. Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol (2004) 93:1178–81.[CrossRef][Web of Science][Medline]
[16] Gorcsan J 3rd, Tanabe M, Bleeker GB, Suffoletto MS, Thomas NC, Saba S, et al. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol (2007) 50:1476–83.
[17] Yu CM, Abraham WT, Bax J, Chung E, Fedewa M, Ghio S, et al. Predictors of response to cardiac resynchronization therapy (PROSPECT)—study design. Am Heart J (2005) 149:600–5.[CrossRef][Web of Science][Medline]
[18] Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation (2002) 105:438–45.
[19] Yu CM, Fung JW, Zhang Q, Chan CK, Chan YS, Lin H, et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation (2004) 110:66–73.
[20] Anderson LJ, Miyazaki C, Sutherland GR, Oh JK. Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy. Circulation (2008) 117:2009–23.
[21] Sogaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BO, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol (2002) 40:723–30.
[22] Sogaard P, Egeblad H, Pedersen AK, Kim WY, Kristensen BO, Hansen PS, et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation (2002) 106:2078–84.
[23] Søgaard P, Kim WY, Jensen HK, Mortensen P, Pedersen AK, Kristensen BØ, et al. Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure. A tissue doppler and three-dimensional echocardiographic study. Cardiology (2001) 95:173–82.[CrossRef][Web of Science][Medline]
[24] Sogaard P, Hassager C. Tissue Doppler imaging as a guide to resynchronization therapy in patients with congestive heart failure. Curr Opin Cardiol (2004) 19:447–51.[CrossRef][Web of Science][Medline]
[25] Penicka M, Bartunek J, De Bruyne B, Vanderheyden M, Goethals M, De Zutter M, et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation (2004) 109:978–83.
[26] Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation (2008) 117:2608–16.
[27] Yu CM, Gorcsan J 3rd, Bleeker GB, Zhang Q, Schalij MJ, Suffoletto MS, et al. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol (2007) 100:1263–70.[CrossRef][Web of Science][Medline]
[28] Yu CM, Zhang Q, Chan YS, Chan CK, Yip GW, Kum LC, et al. Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy. Heart (2006) 92:1452–6.
[29] Notabartolo D, Merlino JD, Smith AL, Delurgio DB, Vera FV, Easley KA, et al. Usefulness of the peak velocity difference by tissue Doppler imaging technique as an effective predictor of response to cardiac resynchronization therapy. Am J Cardiol (2004) 94:817–20.[CrossRef][Web of Science][Medline]
[30] Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol (2003) 91:684–8.[CrossRef][Web of Science][Medline]
[31] Dohi K, Pinsky MR, Kanzaki H, Severyn D, Gorcsan J 3rd. Effects of radial left ventricular dyssynchrony on cardiac performance using quantitative tissue Doppler radial strain imaging. J Am Soc Echocardiogr (2006) 19:475–82.[CrossRef][Web of Science][Medline]
[32] Dohi K, Suffoletto MS, Schwartzman D, Ganz L, Pinsky MR, Gorcsan Iii J. Utility of echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchronization therapy. Am J Cardiol (2005) 96:112–6.[CrossRef][Web of Science][Medline]
[33] Suffoletto MS, Dohi K, Cannesson M, Saba S, Gorcsan J 3rd. Novel speckle tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation (2006) 113:960–8.
[34] Helm RH, Leclercq C, Faris OP, Ozturk C, McVeigh E, Lardo AC, et al. Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: implications for assessing cardiac resynchronization. Circulation (2005) 111:2760–7.
[35] Cazeau S, Bordachar P, Jauvert G, Lazarus A, Alonso C, Vandrell MC, et al. Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol (2003) 26:137–43.[CrossRef][Medline]
[36] Ghio S, Constantin C, Klersy C, Serio A, Fontana A, Campana C, et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. European Heart Journal (2004) 25:571–8.
[37] Achilli A, Peraldo C, Sassara M, Orazi S, Bianchi S, Laurenzi F, et al. Prediction of response to cardiac resynchronization therapy: The Selection of Candidates for CRT (SCART) Study. Pacing Clin Electrophysiol (2006) 29:S11–9.[CrossRef][Medline]
[38] Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and narrow QRS. J Am Coll Cardiol (2003) 42:2117–24.
[39] Richardson M, Freemantle N, Calvert MJ, Cleland JG, Tavazzi L. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. Eur Heart J (2007) 28:1827–34.
[40] Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol (2006) 48:2251–7.
[41] Beshai JF, Grimm R. The resynchronization therapy in narrow QRS study (RethinQ study): methods and protocol design. J Interv Card Electrophysiol (2007) 19:149–55.[CrossRef][Web of Science][Medline]
[42] Beshai JF, Grimm RA, Nagueh SF, Baker JH II, Beau SL, Greenberg SM, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med (2007) 357:2461–71.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





